$14.910
+1.806 (+12.11%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
ADARx Pharmaceuticals, Inc. 株は買うべき？
ADARx Pharmaceuticals is not a good buy right now due to its significant losses and declining stock performance. The current price is $13.15, which is 43.4% below its 52-week high of $23.21. Additionally, the company reported a net income loss of $25,759,000 in Q2 2026, indicating ongoing financial struggles. The main risk is its high price-to-sales ratio of 240.20, suggesting overvaluation relative to its revenue.
ADRX の株価は Thursday に $14.91 で引け、その前に上昇 +12.11%
ADARx Pharmaceuticals, Inc. (ADRX) last closed at $14.9099998, gaining +12.11%. These facts feed the 1-day and 1-week ADRX price prediction above.
予想の要因
ADARx Pharmaceuticals, Inc.（ADRX）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
ADRX の季節性分析
関連記事
- International Stocks vs US Stocks in 2026: How the Strong Dollar and Valuations Change the CaseInternational stocks vs US stocks in 2026: how the strong dollar, valuation gaps, Fed hikes and concentration risk shape a smarter global allocation plan now.
- Defensive Stocks in 2026: Is the Rush Into Staples and Healthcare Already Overcrowded?Investors are piling into defensive stocks as tech slides. See why staples and healthcare surged, why valuations look stretched, and how to avoid overpaying.
- Defense Stocks in 2026: How Midterms, the Iran War and a Stalled Budget Shape the OutlookDefense stocks fell after the 2026 midterms. Learn how the Iran war, the $1.5T budget request and the December 11 funding deadline shape the sector outlook.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。